Browse By Region

Browse By Category
Recent News
By Category: Public Health
WHO Widens Biosurveillance Advisory for Novel Coronavirus
A man from Qatar has been confirmed as the latest patient sickened by a new strain of coronavirus, causing the World Health Organization (WHO) to raise the alert for increased biosurveillance of the SARS-related virus. Health officials are investigating whether the novel virus … Continue reading →
- November 26, 2012
- | Filed under Public Health
PhilHealth says it has enough funds to help dengue victims
(Inquirer News) The Philippine Health Insurance Corp. has assured the public that it has enough funds to help dengue victims after the number of dengue cases in the country rose by 25 percent. Doctor Eduardo Banzon, PhilHealth president and chief executive officer, said the agency provides P8,000 for each case of dengue fever or simple Read More »
- November 23, 2012
- | Filed under Asia/Pacific, North America, Agents & Toxins, International, Policy & Initiatives, and Public Health
A Single Dose of Medicago’s H5N1 VLP Vaccine Protects Against Additional Pandemic Flu Strains in a Preclinical Study
(Market Watch) Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced results from an independent preclinical study on the cross-protection effects of Medicago’s H5N1 VLP vaccine candidate (“H5N1 VLP vaccine”). The study was conducted under the National Institute of Allergy Read More »
- November 21, 2012
- | Filed under North America, Agents & Toxins, Public Health, and Research
FDA Panel OKs Bird Flu Vaccine Stockpiling
(770kkob) A vaccine for the H5N1 avian flu, or bird flu, has been approved by a panel of experts to be stockpiled for emergency use in case of a pandemic. A U.S. Food and Drug Administration advisory panel voted 14-0 in favor that the vaccine, manufactured by GlaxoSmithKline (GSK) in Quebec, was in compliance with Read More »
- November 20, 2012
- | Filed under North America, Agents & Toxins, Public Health, and Research
Texas Biomed files patent for a novel HIV vaccine strategy
(EurekAlert) The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites of contact with the virus. Designed to be a single dose and last a lifetime, the vaccine will lead Read More »
- November 20, 2012
- | Filed under North America, Agents & Toxins, Public Health, and Research